Specific Clearance of Lipopolysaccharide from Blood Based on Peptide Bottlebrush Polymer for Sepsis Therapy
Authors:
- 5 July 2023
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 35 (33) , e2302560
Abstract
Lipopolysaccharide (LPS) is the primary bacterial toxin that is vital to the pathogenesis and progression of sepsis associated with extremely high morbidity and mortality worldwide. However, specific clearance of LPS from circulating blood is highly challenging because of the structural complexity and its variation between/within bacterial species. Herein, a robust strategy based on phage display screening and hemocompatible peptide bottlebrush polymer design for specific clearance of targeted LPS from circulating blood is proposed. Using LPS extracted from Escherichia coli as an example, a novel peptide (HWKAVNWLKPWT) with high affinity (KD < 1.0 nм), specificity, and neutralization activity (95.9 ± 0.1%) against the targeted LPS is discovered via iterative affinity selection coupled with endotoxin detoxification screening. A hemocompatible bottlebrush polymer bearing the short peptide [poly(PEGMEA‐co‐PEP‐1)] exhibits high LPS selectivity to reduce circulating LPS level from 2.63 ± 0.01 to 0.78 ± 0.05 EU mL−1 in sepsis rabbits via extracorporeal hemoperfusion (LPS clearance ratio > 70%), reversing the LPS‐induced leukocytopenia and multiple organ damages significantly. This work provides a universal paradigm for developing a highly selective hemoadsorbent library fully covering the LPS family, which is promising to create a new era of precision medicine in sepsis therapy.Keywords
Funding Information
- National Natural Science Foundation of China (21922411, 22174138)
- National Key Research and Development Program of China (2022YFC3400800)
This publication has 50 references indexed in Scilit:
- Blood compatible materials: state of the artJournal of Materials Chemistry B, 2014
- Structural basis for lipopolysaccharide insertion in the bacterial outer membraneNature, 2014
- The new normal: immunomodulatory agents against sepsis immune suppressionTrends in Molecular Medicine, 2014
- Antibiotic resistance—the need for global solutionsThe Lancet Infectious Diseases, 2013
- Severe Sepsis and Septic ShockNew England Journal of Medicine, 2013
- Short Synthetic β‐Sheet Forming Peptide Amphiphiles as Broad Spectrum Antimicrobials with Antibiofilm and Endotoxin Neutralizing CapabilitiesAdvanced Functional Materials, 2013
- Modification of polyethersulfone membranes – A review of methodsProgress in Materials Science, 2013
- Endotoxin removal devices for the treatment of sepsis and septic shockThe Lancet Infectious Diseases, 2011
- The molecular basis of the host response to lipopolysaccharideNature Reviews Microbiology, 2009
- Effective Binding and Sensing of Lipopolysaccharide: Combining Complementary Pattern Recognition ReceptorsAngewandte Chemie International Edition, 2008